https://www.selleckchem.com/pe....ptide/bulevirtide-my
3 and 2.4 log IU/mL were not detected. The clinical sensitivity and specificity of previously tested DBS was 94% and 100% respectively, with two samples reported as low level RNA positive on the m2000 testing negative on Alinty m. The data suggests that DBS can be used as an off-label specimen type on the Alinity m HCV assay. Allowing continuous, random access testing of DBS simultaneously alongside other Alintiy m assays, potentially improving test turn-around times. The data suggests that DBS can be used as an off-label
Like
Comment
Share
